1. P223 Once-daily low-dose indacaterol/mometasone via breezhaler® reduces exacerbations in patients with inadequately controlled asthma: phase III QUARTZ study. (12th November 2019) Authors: Kornmann, O; Mucsi, J; Kolosa, N; Bandelli, L; Satlin, LC; Sen, B; D'Andrea, P Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗